These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11889527)

  • 1. Plasma levels of natriuretic peptide and echocardiographic parameters in patients with Duchenne's progressive muscular dystrophy.
    Mori K; Manabe T; Nii M; Hayabuchi Y; Kuroda Y; Tatara K
    Pediatr Cardiol; 2002; 23(2):160-6. PubMed ID: 11889527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natriuretic peptides during the development of doxorubicin-induced left ventricular diastolic dysfunction.
    Nousiainen T; Vanninen E; Jantunen E; Puustinen J; Remes J; Rantala A; Vuolteenaho O; Hartikainen J
    J Intern Med; 2002 Mar; 251(3):228-34. PubMed ID: 11886482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diastolic dysfunction and natriuretic peptides in systolic heart failure. Higher ANP and BNP levels are associated with the restrictive filling pattern.
    Yu CM; Sanderson JE; Shum IO; Chan S; Yeung LY; Hung YT; Cockram CS; Woo KS
    Eur Heart J; 1996 Nov; 17(11):1694-702. PubMed ID: 8922918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-type natriuretic peptide and cardiac dysfunction in Duchenne muscular dystrophy.
    Mohyuddin T; Jacobs IB; Bahler RC
    Int J Cardiol; 2007 Jul; 119(3):389-91. PubMed ID: 17079036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natriuretic peptides in patients with diastolic dysfunction due to idiopathic dilated cardiomyopathy.
    Fruhwald FM; Fahrleitner A; Watzinger N; Fruhwald S; Dobnig H; Schumacher M; Maier R; Zweiker R; Klein WW
    Eur Heart J; 1999 Oct; 20(19):1415-23. PubMed ID: 10487802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of atrial natriuretic peptide B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction.
    Davidson NC; Naas AA; Hanson JK; Kennedy NS; Coutie WJ; Struthers AD
    Am J Cardiol; 1996 Apr; 77(10):828-31. PubMed ID: 8623734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Markedly High B-type Natriuretic Peptide Level in a Patient with Duchenne Muscular Dystrophy and Left Ventricular Non-Compaction.
    Misumi I; Nishida Y; Honda T; Kurokawa H; Yasuda H; Kaikita K; Hokimoto S; Ogawa H
    Intern Med; 2015; 54(17):2197-200. PubMed ID: 26328646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma levels of natriuretic peptides in relation to doxorubicin-induced cardiotoxicity and cardiac function in children with cancer.
    Hayakawa H; Komada Y; Hirayama M; Hori H; Ito M; Sakurai M
    Med Pediatr Oncol; 2001 Jul; 37(1):4-9. PubMed ID: 11466716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma B-type natriuretic peptide reflects left ventricular hypertrophy and diastolic function in hypertension.
    Uusimaa P; Tokola H; Ylitalo A; Vuolteenaho O; Ruskoaho H; Risteli J; Linnaluoto M; Peuhkurinen K;
    Int J Cardiol; 2004 Nov; 97(2):251-6. PubMed ID: 15458692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure.
    Passino C; Maria Sironi A; Favilli B; Poletti R; Prontera C; Ripoli A; Lombardi M; Emdin M
    Int J Cardiol; 2005 Sep; 104(1):39-45. PubMed ID: 16137508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between plasma natriuretic peptides and echocardiographic abnormalities in geriatric outpatients.
    Rutten JH; van der Velde N; van der Cammen TJ; ten Cate FJ; Vletter WB; Boomsma F; van den Meiracker AH
    Arch Gerontol Geriatr; 2008; 47(2):189-99. PubMed ID: 17900714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial performance index and atrial ejection force in patients with Duchenne's muscular dystrophy.
    Shabanian R; Aboozari M; Kiani A; Seifirad S; Zamani G; Nahalimoghaddam A; Kocharian A
    Echocardiography; 2011 Nov; 28(10):1088-94. PubMed ID: 21967284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BNP and ANP as diagnostic and predictive markers in heart failure with left ventricular systolic dysfunction.
    Falcão LM; Pinto F; Ravara L; van Zwieten PA
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):121-9. PubMed ID: 15526247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical significance of plasma atrial and brain natriuretic peptide levels during hemodialysis in hemodialysis patients with old myocardial infarction].
    Uetake S; Takahashi M; Tamano K; Honda T; Kobayashi T; Horinaka S
    J Cardiol; 2001 Aug; 38(2):61-71. PubMed ID: 11525111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-type natriuretic peptide level in the diagnosis of asymptomatic diastolic dysfunction.
    Karaca I; Gülcü E; Yavuzkir M; Dağli N; Ilkay E; Ozbay Y; Işik A; Arslan N
    Anadolu Kardiyol Derg; 2007 Sep; 7(3):262-7. PubMed ID: 17785213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of left ventricle diastolic function on natriuretic peptides levels in patients with atrial fibrillation.
    Bakowski D; Wozakowska-Kaplon B; Opolski G
    Pacing Clin Electrophysiol; 2009 Jun; 32(6):745-52. PubMed ID: 19545336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reference ranges for natriuretic peptides for diagnostic use are dependent on age, gender and heart rate.
    Loke I; Squire IB; Davies JE; Ng LL
    Eur J Heart Fail; 2003 Oct; 5(5):599-606. PubMed ID: 14607197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natriuretic peptides and the prevalence of congestive heart failure in patients with pacemakers.
    Gwechenberger M; Huelsmann M; Graf S; Berger R; Bonderman D; Stanek B; Rauscha F; Pacher R
    Eur J Clin Invest; 2004 Dec; 34(12):811-7. PubMed ID: 15606723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial and brain natriuretic peptide and endothelin-1 concentration in patients with idiopathic arterial hypertension: the dependence on the selected morphological parameters.
    Irzmański R; Banach M; Piechota M; Kowalski J; Barylski M; Cierniewski C; Pawlicki L
    Clin Exp Hypertens; 2007 Apr; 29(3):149-64. PubMed ID: 17497342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natriuretic peptides as markers of preclinical cardiac disease in obesity.
    Grandi AM; Laurita E; Selva E; Piantanida E; Imperiale D; Giovanella L; Guasti L; Venco A
    Eur J Clin Invest; 2004 May; 34(5):342-8. PubMed ID: 15147331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.